Only 2% of the world’s profoundly deaf patients have received cochlear implant treatment since it’s invention 40 years ago.
This is due to three major factors: lifestyle, technology drawbacks and cost. 20% of profoundly deaf patients (who live in higher income geographies), choose to receive no treatment due to the lifestyle restrictions and poor sound quality of the current technology. The externally placed sound processing components of current cochlear implants are extremely delicate parts that require significant lifestyle changes to prevent damage.
So while the technology has transformed the lives of over 350,000 profoundly deaf cochlear implant wearers worldwide, there's still a long way to go to make this treatment work for all profoundly deaf patients.
Hemideina will provide a more accessible treatment for all profoundly deaf patients, enabling them to live a life without limits.
Our product, the Hera Wireless Implant, is a fully internalized hearing implant that replaces the external components of the current Cochlear Implant technology, removing the associated lifestyle restrictions and user frustrations by improving sound quality and device functionality. The product is a 2-component system comprising an in-ear bud sound processor, that sits out of sight in the ear canal, and an electrode, implanted in the cochlea, connected by wireless communication to the in-ear bud. Hemideina’s technology overcomes multiple technical and lifestyle challenges associated with the current treatment - battery life, sound quality, signal processing efficiency and usability.